Opinion
China's 2025 action plan: an expanded playbook for foreign investors
As the country shifts toward precision medicine and biotech innovation foreign firms like Roche Novartis and Merck Co are well positioned to leverage Chinas vast patient data and...
2025-03-05 10:00